Back
Reliance, Inc. 10K Form
Buy
54
RS
Reliance, Inc.
Last Price:
$288.22
Seasonality Move:
8.11%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2023-11-02 | 10Q | RS/Reliance, Inc. Quarterly |
| 2023-08-03 | 10Q | RS/Reliance, Inc. Quarterly |
| 2023-05-04 | 10Q | RS/Reliance, Inc. Quarterly |
| 2022-11-03 | 10Q | RS/Reliance, Inc. Quarterly |
| 2022-08-04 | 10Q | RS/Reliance, Inc. Quarterly |
| 2022-05-05 | 10Q | RS/Reliance, Inc. Quarterly |
Receive RS News And Ratings
See the #1 stock for the next 7 days that we like better than RS
RS Financial Statistics
Sales & Book Value
| Annual Sales: | $13.8B |
|---|---|
| Cash Flow: | $180.6M |
| Price / Cash Flow: | 23.24 |
| Annual Sales: | $139.46 |
| Price / Book: | 2.06 |
Profitability
| EPS (TTM): | 13.67370 |
|---|---|
| Net Income (TTM): | $730.7M |
| Gross Margin: | $3.8B |
| Return on Equity: | 10.07% |
| Return on Assets: | 7.05% |
Reliance, Inc. Earnings Forecast
Key Reliance, Inc. Financial Ratios
-
The Gross Profit Margin over the past 32 years for RS is 27.74%.
-
The Selling, General & Administrative Expenses for RS have been equal to 19.27% of Gross Profit Margin.
-
The Research & Development expenses have been 0.00% of Revenue.
-
The Interest Expense is 4.59% of Operating Income.
-
The Net Earning history of RS is 6.35% of Total Revenues.
-
Per Share Earnings over the last 32 years have been positive in 22 years.
Reliance, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Metals & Mining |
| Sector: | Materials |
| Current Symbol: | RS |
| CUSIP: | 759509 |
| Website: | reliance.com |
Debt
| Debt-to-Equity Ratio: | 0.23 |
|---|---|
| Current Ratio: | 4.43 |
| Quick Ratio: | 1.99 |
Price-to-Earnings
| Trailing P/E Ratio: | 18.34 |
|---|---|
| Forward P/E Ratio: | 15.71 |
RS Technical Analysis vs Fundamental Analysis
Buy
54
Reliance, Inc. (RS)
is a Buy
Is Reliance, Inc. a Buy or a Sell?
-
Reliance, Inc. stock is rated a BuyThe current Reliance, Inc. [RS] share price is $288.01. The Score for RS is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.